mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.035 |
0.2 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.2 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |